Yungjin Pharm Co Ltd (003520) — Capital Reinvestment Ratio
Latest as of September 2025:
0.31x
Yungjin Pharm Co Ltd (003520) has a Capital Reinvestment Ratio of 0.31x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩7.00 Billion) in capital expenditures (₩2.16 Billion). See Yungjin Pharm Co Ltd (003520) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.31x
Capex / Operating Cash Flow
Operating Cash Flow
₩7.00 Billion
KRW
Capital Expenditures
₩2.16 Billion
KRW
Data as of
Sep 2025
Most recent filing
Yungjin Pharm Co Ltd Capital Reinvestment Ratio (2013–2024)
This chart tracks Yungjin Pharm Co Ltd's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Yungjin Pharm Co Ltd (2013–2024)
Year-by-year Capital Reinvestment Ratio for Yungjin Pharm Co Ltd from 2013 to 2024. For live market cap and broader valuation context, see 003520 market cap.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.99x | ₩21.74 Billion | ₩21.61 Billion | ▼ -26.5% |
| 2021 | 1.35x | ₩8.37 Billion | ₩11.32 Billion | ▲ +211.1% |
| 2020 | 0.43x | ₩14.50 Billion | ₩6.30 Billion | ▼ -61.0% |
| 2019 | 1.12x | ₩9.28 Billion | ₩10.36 Billion | ▼ -69.8% |
| 2018 | 3.69x | ₩1.27 Billion | ₩4.71 Billion | ▲ +9.9% |
| 2017 | 3.36x | ₩3.15 Billion | ₩10.59 Billion | ▲ +122.8% |
| 2016 | 1.51x | ₩3.11 Billion | ₩4.69 Billion | ▼ -3.5% |
| 2015 | 1.56x | ₩8.80 Billion | ₩13.75 Billion | ▼ -14.1% |
| 2014 | 1.82x | ₩6.22 Billion | ₩11.30 Billion | ▲ +63.3% |
| 2013 | 1.11x | ₩5.95 Billion | ₩6.63 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow